rescon Summit 2025
event information
1 Conference | 20+ Speakers | 80+ Industry Leaders
Inhalation & Respiratory
drug delivery |
Connected Devices
RESCON
RESCON Summit 2025 is the leading strategic event for senior executives driving innovation in inhalation and respiratory drug delivery. Taking place on November 5–6, 2025, in San Francisco, the summit brings together global leaders from pharma, biotech, and device industries to explore the latest trends, technologies, and business strategies shaping the future of inhaled therapeutics.
This year’s program focuses on high-impact innovations across the full development spectrum — from small molecules and LNPs to smart inhalers, AI-powered design, and digital health integration. With a strong emphasis on commercial viability, regulatory navigation, and partnership building, RESCON Summit 2025 is designed for decision-makers seeking actionable insights and meaningful connections in this rapidly evolving field.
Whether you’re developing next-gen respiratory therapies, advancing connected drug-device solutions, or navigating market access pathways, RESCON offers a uniquely curated platform to engage with industry pioneers, regulatory experts, and commercial leaders — all in one place.
What you will get
01
02
03
04
learn
The key practical points 2025
1. Next-Generation Inhalation & Nasal Delivery Platforms
Gain exposure to the latest in non-invasive drug delivery systems, including soft mist inhalers, nasal powders, and epithelial delivery routes, aiming to eliminate syringes and expand therapeutic access.
2. Formulation Innovation: From Nanocarriers to Combination Therapies
Explore formulation strategies for inhalable nanocarriers, microparticles, and combination products, optimizing lung targeting, therapeutic efficacy, and stability.
3. Dry Powder Inhalers: Performance, Usability & Testing
Understand how engineering design, realistic testing models, and patient-centric considerations impact the real-world performance and acceptance of DPIs.
4. Predictive Preclinical Models & Translational Development
Discover integrated approaches combining human ex vivo and in vivo data to enhance the safety, efficacy, and predictivity of respiratory drug development.
5. Digital Health Integration & Smart Device Innovation
See how digital inhalers, remote monitoring, and connected health platforms are shaping the future of adherence tracking, clinical insights, and patient engagement.
6. Regulatory Strategy for Inhaled Combination Products
Navigate FDA and EMA pathways for complex inhaled combination products, including considerations for nebulized gene therapies and evolving environmental standards.
7. Sustainable Design & Green Propellant Transition
Learn how the transition to low global warming potential (GWP) propellants and eco-conscious design is reshaping the respiratory device landscape.
8. Health Economics & Real-World Evidence in Respiratory Disease
Analyze how open and closed claims data, cost-of-illness studies, and economic modeling inform access strategies for rare and chronic respiratory conditions.
9. Patient-Centric Innovation in Inhaled Therapeutics
Examine how usability studies, connected technologies, and human factors research drive more intuitive and effective inhalation therapies tailored to patient needs.
10. Emerging Trends in Inhaled Biologics & Airway Remodeling
Understand scientific advancements in airway mucosal remodeling, aerosol therapy, and the potential of inhaled biologics and ions for systemic and localized effects
what
you’ll discover at conference
Over 25+ Sessions , several networking opportunities in a special venue chosen by our team makes this event unique and unforgettable
who
Should attend
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments of:
- Respiratory Drug Development
- Generics & Respiratory
- Inhalation Drug Delivery Technologies
- Device Development and Engineering
- Respiratory Pharmacology
- Medical Devices & Injectors
- Inhalation Device Development
- Inhaled Formulation Science
- Inhalation Product Development
- Respiratory Regulations
- Generics & Respiratory
- Inhalation Process Development
- Respiratory Medicine
- E-Health
- Inhaled Dosage Forms
- Outsourcing
- Process Development
- Respiratory Pharmacology
- Device Engineering
- Drug Delivery Innovation
- Inhalation Devices
- On-Body Injectors
- Metered Dose Inhaler Development
- Medical Marketing
- Respiratory R&D
- Particle Characterisation
- Business Development
- New Delivery Technologies
- Connective Health
- Pulmonary Disease
- Scientific Research
- Packaging
- Wearable Devices
Meet
The Speakers 2025
David Edwards
register now
rescon summit
5-6 November, 2025 | Hyatt Centric Fisherman’s Wharf****
San Francisco, California, USA
Registration price
$1,695
- 2-Days Full-Access
- Coffee-Breaks & Lunches
- e-Poster Display
- Documentation Package
INHALATION & RESPIRATORY DRUG DELIVERY | CONNECTED DEVICES
© 2017 Copyright All Rights Reserved | Powered by EPM Group